Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Does anyone have insight on how much / specific changes in the spike protein would be needed to render the mRNA vaccines - which to my understanding create only those spikes - would be render less effective or not effective?

Is that a concern here?



Page 8 of https://www.cogconsortium.uk/wp-content/uploads/2020/12/Repo... hints towards this.

The short answer is that 'The extent to which SARS-CoV-2 may evolve to escape immunity induced by infection or vaccination is not currently known'. However analysis has been carried out to work out how far from the receptor-binding site the mutations are, and how 'antibody-accessible' these are, with a few such as . No conclusions are drawn from this analysis.

Earlier on in the report (towards the end of page 1), this statement is given `One of these (the N501Y mutation) occurs in the region of the Spike protein, the receptor binding domain (RBD), that the virus uses to bind to the human ACE2 receptor. Changes in this region of the Spike protein can result in the virus changing its ACE2 binding specificity and alter antibody recognition`.

Saying all this, vaccines are designed to create a range of antibody responses, in order to stop this very fear of a single mutation rendering a whole vaccine useless. [https://www.nature.com/articles/d41586-020-02544-6] I also recall reading somewhere that adapting the vaccine to account for a mutation (much like is done yearly with the flue vaccine) is relatively easy, though I haven't managed to find that article again yet.


Thanks for all this detail.

That's my laymen's guess at the end - even if spike changes too much we can just fire up a new yearly vaccine, maybe bundle with the flu.


Wasn’t Moderna’s vaccine started in January - like a few days after first genome sequence was published...




Consider applying for YC's Winter 2026 batch! Applications are open till Nov 10

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: